CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $46,081,485 | -25.0% | 1,691,374 | -38.7% | 0.12% | -19.1% |
Q2 2023 | $61,416,586 | +2.7% | 2,760,296 | 0.0% | 0.15% | +1.3% |
Q1 2023 | $59,788,011 | -10.0% | 2,760,296 | -15.6% | 0.15% | -18.5% |
Q4 2022 | $66,451,781 | -53.3% | 3,271,875 | -41.1% | 0.18% | -55.9% |
Q3 2022 | $142,323,000 | +8.1% | 5,550,800 | +0.2% | 0.42% | +16.5% |
Q2 2022 | $131,670,000 | +23.3% | 5,537,000 | +16.8% | 0.36% | +48.5% |
Q1 2022 | $106,754,000 | +16.6% | 4,740,420 | +2.5% | 0.24% | +41.8% |
Q4 2021 | $91,592,000 | +20.5% | 4,625,849 | +19.8% | 0.17% | +17.2% |
Q3 2021 | $75,985,000 | -32.0% | 3,861,000 | -23.9% | 0.14% | -30.3% |
Q2 2021 | $111,683,000 | -7.5% | 5,076,507 | 0.0% | 0.21% | -11.1% |
Q1 2021 | $120,770,000 | -9.1% | 5,076,507 | 0.0% | 0.23% | -14.0% |
Q4 2020 | $132,801,000 | +46.8% | 5,076,507 | -2.3% | 0.27% | +28.3% |
Q3 2020 | $90,457,000 | +5.6% | 5,197,213 | +2.0% | 0.21% | 0.0% |
Q2 2020 | $85,684,000 | +38.1% | 5,094,181 | -2.4% | 0.21% | +16.5% |
Q1 2020 | $62,028,000 | -42.2% | 5,216,832 | -41.2% | 0.18% | -23.8% |
Q4 2019 | $107,380,000 | -17.8% | 8,874,400 | -4.0% | 0.24% | -25.5% |
Q3 2019 | $130,631,000 | +14.1% | 9,241,700 | -10.0% | 0.32% | +15.5% |
Q2 2019 | $114,512,000 | -12.7% | 10,270,092 | -8.1% | 0.28% | -14.5% |
Q1 2019 | $131,210,000 | -15.4% | 11,176,281 | -3.7% | 0.32% | -23.2% |
Q4 2018 | $155,040,000 | -8.5% | 11,604,789 | -4.0% | 0.42% | +7.1% |
Q3 2018 | $169,499,000 | -9.5% | 12,089,820 | +1.4% | 0.40% | -28.1% |
Q2 2018 | $187,384,000 | -10.2% | 11,920,108 | -6.0% | 0.55% | -9.4% |
Q1 2018 | $208,697,000 | -8.5% | 12,686,727 | +0.5% | 0.61% | -5.8% |
Q4 2017 | $227,990,000 | -0.9% | 12,624,012 | +5.9% | 0.64% | -2.6% |
Q3 2017 | $229,975,000 | +37.8% | 11,915,793 | -15.7% | 0.66% | +37.5% |
Q2 2017 | $166,879,000 | +4.6% | 14,142,295 | -2.9% | 0.48% | +5.5% |
Q1 2017 | $159,550,000 | +58.4% | 14,557,457 | +4.9% | 0.46% | +50.7% |
Q4 2016 | $100,754,000 | +11.7% | 13,878,000 | -0.0% | 0.30% | +16.2% |
Q3 2016 | $90,220,000 | +19.0% | 13,879,968 | 0.0% | 0.26% | +17.6% |
Q2 2016 | $75,785,000 | +14.1% | 13,879,968 | -2.2% | 0.22% | +7.3% |
Q1 2016 | $66,406,000 | -6.0% | 14,189,245 | 0.0% | 0.21% | -8.0% |
Q4 2015 | $70,662,000 | +32.6% | 14,189,245 | +0.1% | 0.22% | +29.5% |
Q3 2015 | $53,303,000 | -37.4% | 14,176,305 | +0.1% | 0.17% | -32.2% |
Q2 2015 | $85,097,000 | +7.5% | 14,159,245 | +0.1% | 0.26% | +5.8% |
Q1 2015 | $79,192,000 | +99.8% | 14,141,470 | +7.0% | 0.24% | +97.5% |
Q4 2014 | $39,637,000 | +10.9% | 13,212,448 | -0.9% | 0.12% | +6.1% |
Q3 2014 | $35,740,000 | -4.3% | 13,335,690 | 0.0% | 0.12% | -1.7% |
Q2 2014 | $37,340,000 | -30.0% | 13,335,690 | +9.0% | 0.12% | -34.3% |
Q1 2014 | $53,340,000 | +42.0% | 12,233,892 | +4.9% | 0.18% | +36.9% |
Q4 2013 | $37,559,000 | +102.5% | 11,664,876 | 0.0% | 0.13% | +83.1% |
Q3 2013 | $18,547,000 | -9.5% | 11,664,876 | -1.5% | 0.07% | -12.3% |
Q2 2013 | $20,488,000 | – | 11,842,542 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |